By asianet
Alfasigma S.p.A. has completed the acquisition of SOFAR S.p.A., thus officially beginning the integrating process of the two companies. The transaction, which was launched last August and was scheduled for completion in October 2022, was successfully completed in full compliance with the planned timeline. Alfasigma is one of the leading multinational pharmaceutical companies with over … Continued
By asianet
*CHP’s AdCheck independent advertising advisory service creates content management and communication efficiencies for members Veeva Systems(https://www.veeva.com/) (NYSE: VEEV) today announced that AdCheck(https://www.chpaustralia.com.au/AdCheck), an independent advertising advisory service provided by Consumer Healthcare Products (CHP) Australia(https://www.chpaustralia.com.au/Home), is leveraging Veeva Vault PromoMats to create a single hub of content for its clients’ Therapeutic Goods Advertising Code (TGAC) applications. “Veeva … Continued
By asianet
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to provide a first booster dose at least six months after completion of primary … Continued
By asianet
Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of $35M and upfront closing payment of $200M, regulatory achievement milestones of up to $125M and commercial milestones of up to $775M through 2029 for a total consideration of up to $1.135 … Continued
By asianet
–Study evaluates AB-101a for patients with and without concurrent bacterial infection Alphyn Biologics ( https://c212.net/c/link/?t=0&l=en&o=3680049-1&h=958198912&u=https%3A%2F%2Falphynbiologics.com%2F&a=Alphyn+Biologics ), a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today that enrollment in its Phase2a clinical trial of AB-101a for mild-to-moderate atopic dermatitis (AD) has passed the halfway point. The randomized, vehicle-controlled, double-blind trial is evaluating AB-101a for the … Continued
By asianet
— Loaded with innovation and technology, CSafeAPS provides superior temperature control and the industry’s only in-transit thermal capacity indicator CSafe ( https://c212.net/c/link/?t=0&l=en&o=3680585-1&h=2567441145&u=https%3A%2F%2Fcsafeglobal.com%2F&a=CSafe ), the largest provider of a complete range of active and passive temperature-controlled shipping solutions for the pharmaceutical industry, announced today the launch of its new advanced reusable pallet shipper, CSafeAPS ( https://c212.net/c/link/?t=0&l=en&o=3680585-1&h=390496093&u=https%3A%2F%2Fhubs.li%2FQ01pZt6d0&a=CSafeAPS … Continued
By asianet
EditForce, Inc. (hereinafter “EditForce”), headquartered in Fukuoka, Japan, has realized the world’s first RNA-editing technology that enables RNA-editing bases to be changed from “U” to “C,” and demonstrated that this technology works even in human cells in a joint study with Professor Takahiro Nakamura, Faculty of Agriculture, Kyushu University. The study opens up the possibility … Continued
By asianet
Global health in focus The World Health Summit 2022, the world’s leading meeting for global health, began on Sunday morning in Berlin. For the first time it is co-hosted by the World Health Organization (WHO). Among the central topics are climate change and health, pandemic preparedness, sustainable health systems and the role of the G7 … Continued
By asianet
– On Global Handwashing Day, 15 October 2022, the GHC is calling for investment in handwashing education and resources to achieve universal hand hygiene, prevent disease and save lives. Handwashing with soap is one of the most important steps for reducing the spread of infectious diseases. It is substantially less expensive than other public health … Continued
By asianet
On Oct.10, Chengdu Tianfu Global International Biocity saw the signing of ten project agreements totalling nearly 9B CNY in value and covering modern biopharmaceuticals, innovative chemical drugs, sophisticated medical apparatuses and other important fields. Geneseeq, a Chinese genetic disease testing giant, intends to invest in a local facility and industrialization base of genetic infection and … Continued